flunisolide nasal spray, Aerospan (Nasalide, Aerobid, Aerobid HFA are discontinued) (cont.)

Pharmacy Author:
Medical and Pharmacy Editor:

SIDE EFFECTS: The most common side effects of flunisolide are:

Other adverse effects include:



PREPARATIONS: Nasal spray: 0.025 mg or 0.029 mg/spray. Oral Inhaler: 80 mcg/actuation.

STORAGE: Flnisolide should be stored at room temperature between 15 C - 30 C (59 F - 86 F) and should be protected from heat, and direct light.

DOSING: The canister should be shaken before each use.

  • For adults, the usual starting dose is two sprays in each nostril twice daily. The dose may be increased to 3 or 4 times per day.
  • In children ages 6-14 years, the usual starting dose is one spray in each nostril three times per day or two sprays in each nostril twice daily.
  • The adult dose for treating asthma is 2 inhalations twice daily not to exceed 8 inhalations per day.
  • The children's dose for treating asthma is 2 inhalations twice daily.

DRUG INTERACTIONS: No drug interactions have been described with nasal flunisolide

PREGNANCY: Well-controlled studies on the use of flunisolide during pregnancy have not been done. Studies in animals have shown flunisolide to have damaging effects on the fetus. During pregnancy flunisolide should be avoided unless the physician feels that the potential therapeutic benefit justifies the added risk to the fetus.

Medically Reviewed by a Doctor on 5/22/2015

Report Problems to the Food and Drug Administration

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.

Pill Finder Tool

Need help identifying pills and medications?
Use the pill identifier tool on RxList.

Back to Medications Index